Oklahoma 2024 2024 Regular Session

Oklahoma House Bill HB3034 Engrossed / Bill

Filed 02/27/2024

                     
 
ENGR. H. B. NO. 3034 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
ENGROSSED HOUSE 
BILL NO. 3034 	By: Stinson of the House 
 
   and 
 
  Pugh of the Senate 
 
 
 
 
 
 
An Act relating to schools; creating the Emerson Kate 
Cole Act; amending 70 O.S. 2021, Section 1-116.3, 
which relates to school medication policies; 
requiring school to call 911 if Epinephrine is 
administered to a student; mandating school to notify 
parent if student experiences possible allergic 
reaction; requiring annual training for certain 
teachers and school employees; prescribing content 
and method for training; providing for 
noncodification; providing an effective date ; and 
declaring an emergency. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     NEW LAW     A new section of law not to b e 
codified in the Oklahoma Statutes reads as follows: 
This act shall be known and may be cited as the "Emerson Kate 
Cole Act". 
SECTION 2.     AMENDATORY     70 O.S. 2021, Section 1-116.3, is 
amended to read as follows: 
Section 1-116.3 A. Notwithstanding the provisions of Section 
1-116.2 of this title, the board of education of each school 
district shall adopt a pol icy on or before September 1, 2008, that   
 
ENGR. H. B. NO. 3034 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
permits the self-administration of inhaled asthma medication by a 
student for treatment of asthma, the self-administration of 
anaphylaxis medication by a student for treatment of anaphylaxis , 
and the self-administration of replacement pancreatic enzymes by a 
student for treatment of cystic fibrosis.  The policy shall require: 
1.  The parent or guardian of the student to authorize in 
writing the student's self-administration of medication; 
2.  The parent or guardian of the student to provide to the 
school a written statement from t he physician treating the student 
that the student has asthm a, anaphylaxis, or cystic fibrosis and is 
capable of, and has been instructed in the proper method of, self -
administration of medicat ion; 
3.  The parent or guardian of the student to provide to th e 
school an emergency supply of the student 's medication to be 
administered pursuant to the provisions of Section 1 -116.2 of this 
title; 
4.  The school district to inform the parent or guardian of the 
student, in writing, that the school district and its e mployees and 
agents shall incur no liability as a result of any injury arising 
from the self-administration of medication by the student; and 
5.  The parent or guardian of the student to sign a statement 
acknowledging that the school district shall incur n o liability as a 
result of any injury arising from the self -administration of 
medication by the student.   
 
ENGR. H. B. NO. 3034 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
B.  The school board of each school district that elects to 
stock Epinephrine injectors or inhalers shall amend the policy 
identified in subsection A of this section. 
1.  The amended policy for Epinephrine injec tors shall require: 
a. the school district to inform the parent or guardian 
of each student, in writing, that a school nurse or 
school employee trained by a health care professional 
or trained in correlation with the State Department of 
Health's Diabetes Management Annual School Training 
Program may administer, with parent or guardian 
permission but without a health care provider order, 
an Epinephrine injection to a student whom the school 
nurse or trained school employee in good faith 
believes is having an anaphylactic reaction, 
b. a waiver of liability executed by a parent or guardian 
be on file with the school district prior to the 
administration of an Epinephrine injection pursuant to 
paragraph 1 of this subsection, and 
c. the school district to designat e the employee 
responsible for obtaining the Epinephrine injectors at 
each school site. 
2.  The amended policy for inhalers shall req uire: 
a. the school district to inform the parent or guardian 
of each student, in writing, that a school nurse or   
 
ENGR. H. B. NO. 3034 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
school employee trained by a health care professional 
may administer an inhaler to a student whom the school 
nurse or trained school employee in good faith 
believes is having respiratory distress, 
b. the school district to designate the employee 
responsible for obtaining the inhalers and spacers or 
holding chambers at each school site, and 
c. the school district to notify the parent or guardian 
of a student after administration of an inhaler. 
C.  The school district and its employees and agents shall incur 
no liability as a result of any injury arising pursuant to the 
discharge or nondischarge of the powers provided for pursuant to 
subparagraph a of paragraphs 1 and 2 of subsection B of this 
section. 
D.  A licensed physician who has prescriptive authority may 
write a prescription for Epinephrine injectors and inhalers and 
spacers or holding chambers to the school district in the name of 
the district as a body corporate specified in Section 5 -105 of this 
title which shall be maintained at each school site.  Such physic ian 
shall incur no liability as a result of any injury arising from the 
use of the Epinephrine injectors or the inhalers and spacers or 
holding chambers. 
E.  The school district may maintain at ea ch school a minimum of 
two Epinephrine injectors and two inh alers with spacers or holding   
 
ENGR. H. B. NO. 3034 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
chambers in a secure location.  Provided, however, that nothing in 
this section shall be construed as c reating or imposing a duty on a 
school district to maintain Epi nephrine injectors or inhalers with 
spacers or holding chamb ers at a school site or sites. 
F.  In the event a student is believed to be having an 
anaphylactic reaction or respiratory distress, a school employee 
shall contact 911 as soon as possible.  If Epinephrine is 
administered to a student, a school employee sh all contact 911 as 
soon as possible. The school district shall notify the parent or 
guardian of any student who experiences a possible allergic reaction 
as soon as possible. 
G.  The State Board o f Education, in consultation with the State 
Board of Health, shall develop model policies which school districts 
may use in compliance with this section.  The model policies shall 
include, at a minimum, required annual training for teachers and 
school employees who are directly responsible for students on the 
topics of food allergies, recognizing anaphylaxis, and instruction 
on how to administer Epi nephrine.  The training shall be completed 
before the school year begins or upon hiring the teacher or school 
employee. Documentation certifying completion of the requir ed 
training shall be retained in the personnel file for the teacher or 
school employee. The training may be provided online or in-person 
by the school nurse or a recognized food allergy and anaphylaxis 
training program.   
 
ENGR. H. B. NO. 3034 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
H.  The State Board of E ducation, in consultation with the State 
Board of Health, shall promulgate rules to implement this section. 
I.  As used in this section: 
1.  "Medication" means a metered dose inhaler or a dry powder 
inhaler to alleviate asthmatic symptoms, prescribed by a physician 
and having an individual label, an anaphylaxis medication used to 
treat anaphylaxis including but not limited to Epinephrine injectors 
prescribed by a physician and having an individual label, or 
replacement pancreatic enzymes prescribed by a phy sician and having 
an individual label; and 
2.  "Self-administration" means a student's use of medication 
pursuant to prescription or written direction from a physician. 
3.  "Respiratory distress " means the perceived or actual 
presence of coughing, wheezing or shortness of breath; and 
4.  "Inhaler" means a device that delivers a bronchodilator to 
alleviate symptoms of respiratory distress that is manufactured in 
the form of a metered -dose inhaler or dry-powder inhaler and that 
may include a spacer or holding chamber that attaches to the inhaler 
to improve the delivery of the bronchodilator. 
J.  The permission for self -administration of asthma, 
anaphylaxis, or replacement pancreatic enzyme medication is 
effective for the school year for which it is granted and shall be 
renewed each subsequent school year upon fulfillment of the 
requirements of this section.   
 
ENGR. H. B. NO. 3034 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
K.  A student who is permitted to self -administer asthma, 
anaphylaxis, or replacement pancreatic enzyme med ication pursuant to 
this section shall be permitted to possess and use a prescribed 
inhaler, anaphylaxis medication including but not limited to an 
Epinephrine injector, or replacement pancreatic enzyme medication at 
all times. 
SECTION 3.  This act shall become effective July 1, 2024. 
SECTION 4.  It being immediately necessary for the preservation 
of the public peace, health or safety, an emergency is hereby 
declared to exist, by reason whereof thi s act shall take effect and 
be in full force from and after its passage and approval. 
Passed the House of R epresentatives the 26th day of February, 
2024. 
 
 
 
  
 	Presiding Officer of the House 
 	of Representatives 
 
 
Passed the Senate the ___ day of __________, 2024. 
 
 
 
  
 	Presiding Officer of the Senate